BioCentury
ARTICLE | Clinical News

Tekron: Started Phase II trial

August 2, 1993 7:00 AM UTC

Telor Ophthalmic Pharmaceuticals Inc. (TELR) Product:Tekron, formulation of ethacrynic acid Indication: Controlling elevated intraocular pressure associated with glaucoma and ocular hypertension Stat...